Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Tulathromycin is a semi-synthetic macrolide antibiotic primarily used in veterinary medicine to treat respiratory diseases in cattle and swine caused by Gram-positive and certain Gram-negative bacteria. Structurally, tulathromycin features a 15-membered ring, distinguishing it from other macrolides and enhancing its pharmacokinetic properties such as tissue penetration and prolonged activity. Its mechanism of action involves inhibiting protein synthesis by binding to the bacterial 23S ribosomal RNA component of the 50S subunit, thereby impeding the growth and reproduction of bacteria. Administered commonly via subcutaneous or intramuscular injection, tulathromycin provides rapid therapeutic effects with a long-lasting efficacy profile, often requiring only a single dose for effective treatment. Due to concerns about antibiotic resistance, its use is accompanied by strict guidelines to ensure responsible administration within livestock management. Research continues to explore tulathromycin's pharmacodynamics and environmental implications post-excretion.
仅用于科研。不用于诊断过程。未经明确授权不得转售。